April 10th 2025
How pharma manufacturers can steadily navigate GTN components and complexities when planning pharmacy benefit reimbursement.
February 26th 2025
What Round II of Medicare Part D Drug Prices Signify for the Pharma Industry
January 30th 2025In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, value & access advisor for Schoonveld Advisory and author of The Price of Global Health, comments on the future implications of the latest CMS drug price negotiations.